UBS Group »

Oric Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $377k 41k 9.20
2023-09-30 $105k 17k 6.05
2023-06-30 $173k 22k 7.76
2022-12-31 $26k 4.4k 5.89
2022-09-30 $0 133 0.00
2022-06-30 $10k 2.2k 4.54
2021-12-31 $917k 62k 14.70
2021-09-30 $544k 26k 20.92
2021-06-30 $128k 7.2k 17.68
2021-03-31 $772k 32k 24.50
2020-12-31 $52k 1.5k 34.05
2020-09-30 $40k 1.6k 24.84
2020-06-30 $96k 2.8k 33.76